Search all 大象APPsites
Menu
National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to healthcare
大象APP
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- Consumer Assessment of Healthcare Providers and Systems (CAHPS庐) Program
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- National Healthcare Quality and Disparities Report Data Tools
- Network of Patient Safety Databases
- 大象APPQuality Indicator Tools for Data Analytics
- Surveys on Patient Safety Culture
- United States Health Information Knowledgebase (USHIK)
- Search Data Sources Available From AHRQ
SHARE:
Search All Research Studies
大象APPResearch Studies
Sign up:
Research Studies is a compilation of published research articles funded by 大象APPor authored by 大象APPresearchers.
Results
1 to 2 of 2 Research Studies DisplayedMaganty A, Kaufman SR, Oerline MK
Value-based payment models and management of newly diagnosed prostate cancer.
This study鈥檚 goal was to examine the effect of urologist participation in value-based payment models on the initial management of men with newly diagnosed prostate cancer. The authors looked at data from Medicare beneficiaries with prostate cancer diagnosed between 2017 and 2019, with 1鈥墆ear of follow-up, who were assigned to their primary urologist, each of whom was then aligned to a value-based payment model (MIPS, accountable care organization, ACO without financial risk, and ACO with risk). Treatment did not vary by payment model, both overall (MIPS-67%, ACOs without risk-66%, ACOs with risk-66%). Similarly, treatment did not vary among men with very high risk of non-cancer mortality by payment model (MIPS-52%, ACOs without risk-52%, ACOs with risk-51%). Adjusted spending was similar across payment models (MIPS-$16,501, ACOs without risk-$16,140, ACOs with risk-$16,117).
AHRQ-funded; HS025707.
Citation: Maganty A, Kaufman SR, Oerline MK .
Value-based payment models and management of newly diagnosed prostate cancer.
Cancer Med 2024 Jan; 13(1):e6810. doi: 10.1002/cam4.6810..
Keywords: Payment, Cancer: Prostate Cancer, Cancer
Modi PK, Kaufman SR, Qi J
National trends in active surveillance for prostate cancer: validation of medicare claims-based algorithms.
This study analyzed the use of active surveillance of low-risk prostate cancer among a wide variety of health care practices. Researchers identified men with prostate cancer from 2012-2014 using a 100% sample of Michigan Medicare data and linked them with the Michigan Urologic Surgery Improvement Collaborative (MUSIC) registry. They analyzed the performance of 8 claims-based algorithms that were used and selected 3 of them to apply to a 20% national Medicare sample. The 3 algorithms were determined to be either the most sensitive, the most specific, and a balanced algorithm incorporating age and comorbidity. They found that use of surveillance for men increased from 2007 to 2014 but there was a large decrease in the rate of prostate cancer diagnosis. The rate of active surveillance either increased or remained stable depending on the algorithm used.
AHRQ-funded; HS025707.
Citation: Modi PK, Kaufman SR, Qi J .
National trends in active surveillance for prostate cancer: validation of medicare claims-based algorithms.
Urology 2018 Oct;120:96-102. doi: 10.1016/j.urology.2018.06.037..
Keywords: Cancer, Cancer: Prostate Cancer, Medicare, Men's Health, Payment
